(Q44214175)

30 November 2017

title

L-DOPA does not cause neurotoxicity in VMAT2 heterozygote knockout mice (English)

1 reference

30 November 2017

0 references

1 reference

1 reference

Maria E Reveron

1

1 reference

30 November 2017

Katerina V Savelieva

2

1 reference

30 November 2017

Jennifer L Tillerson

3

1 reference

30 November 2017

Alison L McCormack

4

1 reference

30 November 2017

Donato A Di Monte

5

1 reference

30 November 2017

Gary W Miller

6

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

23

1 reference

30 November 2017

issue

4-5

1 reference

30 November 2017

page(s)

611-619

1 reference

Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Molecular characterization of the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

The efficiency of systematic sampling in stereology and its prediction.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Levodopa neurotoxicity: experimental studies versus clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Immunochemical analysis of dopamine transporter protein in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Dopamine transporters and neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Differential expression of two vesicular monoamine transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Chronic dopa feeding of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Pharmacology and regulation of the neuronal dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Striatal dopamine deficiency in Parkinson's disease: role of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Withdrawal of repeated cocaine decreases autoradlographic [3H]mazindol-labelling of dopamine transporter In rat nucleus aecumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Does levodopa accelerate Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Murine vesicular monoamine transporter 2: molecular cloning and genomic structure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900037-2

7 January 2021

10.1016/S0161-813X(02)00037-2

Identifiers

DOI

1 reference

30 November 2017

1 reference